位置:首页 > 蛋白库 > TYRDC_LEVBR
TYRDC_LEVBR
ID   TYRDC_LEVBR             Reviewed;         626 AA.
AC   J7GQ11;
DT   13-NOV-2019, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2012, sequence version 1.
DT   03-AUG-2022, entry version 60.
DE   RecName: Full=L-tyrosine decarboxylase {ECO:0000303|PubMed:24211777};
DE            Short=TDC {ECO:0000303|PubMed:24211777};
DE            EC=4.1.1.25 {ECO:0000269|PubMed:24211777, ECO:0000269|PubMed:27292129};
GN   Name=tdc {ECO:0000303|PubMed:24211777, ECO:0000312|EMBL:AFP73381.1};
GN   ORFNames=CNR29_12740 {ECO:0000312|EMBL:PBQ24843.1},
GN   N624_0219 {ECO:0000312|EMBL:KIO94105.1},
GN   UCCLBBS449_2369 {ECO:0000312|EMBL:QCZ54275.1};
OS   Levilactobacillus brevis (Lactobacillus brevis).
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae;
OC   Levilactobacillus.
OX   NCBI_TaxID=1580;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, SUBSTRATE SPECIFICITY, AND
RP   SUBUNIT.
RC   STRAIN=CGMCC 1.2028;
RX   PubMed=24211777; DOI=10.1016/j.pep.2013.10.018;
RA   Zhang K., Ni Y.;
RT   "Tyrosine decarboxylase from Lactobacillus brevis: Soluble expression and
RT   characterization.";
RL   Protein Expr. Purif. 94:33-39(2014).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=TMW 1.313;
RA   Behr J., Preissler P., Geissler A.J., Ehrenreich A., Angelov A.,
RA   Vogel R.F.;
RT   "Identification of ecotype-specific marker genes for categorization of
RT   beer-spoiling Lactobacillus brevis.";
RL   Submitted (JAN-2015) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=D7;
RA   Kwon M.-S., Lim S.K., Choi H.-J.;
RT   "Genome sequence of Lactobacillus brevis D7.";
RL   Submitted (SEP-2017) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=UCCLBBS449;
RA   Feyereisen M.;
RL   Submitted (JUL-2018) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0007744|PDB:5HSI, ECO:0007744|PDB:5HSJ}
RP   X-RAY CRYSTALLOGRAPHY (1.73 ANGSTROMS) OF APOENZYME AND IN COMPLEX WITH
RP   PLP, PYRIDOXAL PHOSPHATE AT LYS-392, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, MUTAGENESIS OF HIS-241; TYR-398;
RP   TYR-420 AND SER-586, AND ACTIVE SITE.
RC   STRAIN=CGMCC 1.2028;
RX   PubMed=27292129; DOI=10.1038/srep27779;
RA   Zhu H., Xu G., Zhang K., Kong X., Han R., Zhou J., Ni Y.;
RT   "Crystal structure of tyrosine decarboxylase and identification of key
RT   residues involved in conformational swing and substrate binding.";
RL   Sci. Rep. 6:27779-27779(2016).
CC   -!- FUNCTION: Catalyzes the decarboxylation of L-tyrosine to produce
CC       tyramine (PubMed:24211777, PubMed:27292129). Cannot use other aromatic
CC       L-amino acids as substrates like L-phenylalanine, L-tryptophan and L-
CC       glutamate (PubMed:24211777). {ECO:0000269|PubMed:24211777,
CC       ECO:0000269|PubMed:27292129}.
CC   -!- FUNCTION: Is also able to decarboxylate the Parkinson's disease
CC       medication levodopa (L-dopa) to dopamine in vitro.
CC       {ECO:0000269|PubMed:24211777, ECO:0000269|PubMed:27292129}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-tyrosine = CO2 + tyramine; Xref=Rhea:RHEA:14345,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:58315,
CC         ChEBI:CHEBI:327995; EC=4.1.1.25;
CC         Evidence={ECO:0000269|PubMed:24211777, ECO:0000269|PubMed:27292129};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14346;
CC         Evidence={ECO:0000305|PubMed:24211777, ECO:0000305|PubMed:27292129};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-dopa = CO2 + dopamine; Xref=Rhea:RHEA:12272,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57504,
CC         ChEBI:CHEBI:59905; Evidence={ECO:0000269|PubMed:24211777,
CC         ECO:0000269|PubMed:27292129};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:24211777};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.59 mM for L-tyrosine {ECO:0000269|PubMed:24211777};
CC         KM=0.6 mM for L-tyrosine {ECO:0000269|PubMed:27292129};
CC         KM=0.8 mM for L-dopa {ECO:0000269|PubMed:27292129};
CC         Vmax=147.1 umol/min/mg enzyme for the decarboxylation of L-tyrosine
CC         {ECO:0000269|PubMed:24211777};
CC         Note=kcat is 343.1 sec(-1) for the decarboxylation of L-tyrosine
CC         (PubMed:24211777). kcat is 124.8 sec(-1) for the decarboxylation of
CC         L-tyrosine. kcat is 76.5 sec(-1) for the decarboxylation of L-dopa
CC         (PubMed:27292129). {ECO:0000269|PubMed:24211777,
CC         ECO:0000269|PubMed:27292129};
CC       pH dependence:
CC         Optimum pH is 5.0 for the decarboxylation of L-tyrosine. Is not
CC         active at pH below 3.5 or above 9.0. More than 90% of activity
CC         remains over pH range from 5.0 to 6.0, and activity decreases rapidly
CC         at pH below 5.0 or higher than 6.0. {ECO:0000269|PubMed:24211777};
CC       Temperature dependence:
CC         Optimum temperature is 50 degrees Celsius. Only 8.5% of activity
CC         remains at 70 degrees Celsius. However, the enzyme shows poor
CC         stability at 50 degrees Celsius, the relative activity dropped to 14%
CC         after 1 h of incubation. {ECO:0000269|PubMed:24211777};
CC   -!- PATHWAY: Amino-acid metabolism. {ECO:0000305|PubMed:24211777}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:24211777,
CC       ECO:0000269|PubMed:27292129}.
CC   -!- MISCELLANEOUS: In gut microbiota this enzyme is in fact exclusively
CC       responsible for the decarboxylation of levodopa, and thus reduces in
CC       situ levels of levodopa in the treatment of Parkinson's disease. It was
CC       shown that abundance of bacterial tyrosine decarboxylase in the
CC       proximal small intestine - the primary site of levodopa absorption
CC       - contributes to interindividual variation in drug efficacy and can
CC       explain the requirement for an increased dosage regimen of levodopa
CC       treatment in Parkinson's disease patients.
CC       {ECO:0000250|UniProtKB:Q838D6}.
CC   -!- SIMILARITY: Belongs to the group II decarboxylase family. Tyrosine
CC       decarboxylase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JX204286; AFP73381.1; -; Genomic_DNA.
DR   EMBL; JXUF01000002; KIO94105.1; -; Genomic_DNA.
DR   EMBL; NVYO01000001; PBQ24843.1; -; Genomic_DNA.
DR   EMBL; CP031198; QCZ54275.1; -; Genomic_DNA.
DR   RefSeq; WP_011668784.1; NZ_QQPA01000097.1.
DR   PDB; 5HSI; X-ray; 1.73 A; A/B=1-626.
DR   PDB; 5HSJ; X-ray; 1.90 A; A/B=1-626.
DR   PDBsum; 5HSI; -.
DR   PDBsum; 5HSJ; -.
DR   AlphaFoldDB; J7GQ11; -.
DR   SMR; J7GQ11; -.
DR   EnsemblBacteria; KIO94105; KIO94105; N624_0219.
DR   EnsemblBacteria; PBQ24843; PBQ24843; CNR29_12740.
DR   PATRIC; fig|1580.52.peg.219; -.
DR   OMA; ANYEGLW; -.
DR   BRENDA; 4.1.1.25; 2851.
DR   Proteomes; UP000217918; Unassembled WGS sequence.
DR   Proteomes; UP000307074; Chromosome.
DR   GO; GO:0036468; F:L-dopa decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0004837; F:tyrosine decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro.
DR   Gene3D; 3.40.640.10; -; 1.
DR   InterPro; IPR002129; PyrdxlP-dep_de-COase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR022397; Tyrosine_deCO2ase_bac.
DR   Pfam; PF00282; Pyridoxal_deC; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR03811; tyr_de_CO2_Ent; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Decarboxylase; Lyase; Pyridoxal phosphate.
FT   CHAIN           1..626
FT                   /note="L-tyrosine decarboxylase"
FT                   /id="PRO_0000448497"
FT   ACT_SITE        420
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:27292129"
FT   BINDING         158..159
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   BINDING         298
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   BINDING         389..391
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   BINDING         440
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   MOD_RES         392
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000269|PubMed:27292129,
FT                   ECO:0007744|PDB:5HSJ"
FT   MUTAGEN         241
FT                   /note="H->A: Complete loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   MUTAGEN         241
FT                   /note="H->N,Q: Almost complete loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   MUTAGEN         398
FT                   /note="Y->A: High decrease in catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   MUTAGEN         420
FT                   /note="Y->A,F: Complete loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   MUTAGEN         586
FT                   /note="S->A: Increase in catalytic efficiency and substrate
FT                   affinity."
FT                   /evidence="ECO:0000269|PubMed:27292129"
FT   HELIX           13..16
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           25..45
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          46..48
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           62..85
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            92..94
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           105..115
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           124..126
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           128..144
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          151..157
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           158..182
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           184..187
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           192..195
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           200..209
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           210..213
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           214..219
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           222..224
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           228..231
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          233..237
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           238..240
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           241..250
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          267..269
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           271..283
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          288..296
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            298..300
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           306..317
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            318..320
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          324..328
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            330..332
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           333..339
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           349..351
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           352..358
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          361..364
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           371..378
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           379..382
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          383..387
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            390..394
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          401..407
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           408..413
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           432..435
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           443..455
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            460..462
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           463..481
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          485..488
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          491..497
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          502..512
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           518..531
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          545..552
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           553..556
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   TURN            557..560
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           561..566
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           571..577
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   STRAND          579..586
FT                   /evidence="ECO:0007829|PDB:5HSI"
FT   HELIX           595..618
FT                   /evidence="ECO:0007829|PDB:5HSI"
SQ   SEQUENCE   626 AA;  70507 MW;  88C111F99D259766 CRC64;
     MEKSNRSLKD LDLNALFIGD KAENGQLYKD LLNKLVDEHL GWRKNYIPSD PNMIGPEDQN
     SPAFKKTVGH MKTVLDQLSE RIRTESVPWH SAGRYWGHMN SETLMPALLA YNYAMLWNGN
     NVAYESSPAT SQMEEEVGQE FARLMGYDYG WGHIVADGSL ANLEGLWYAR NIKSLPFAMK
     EVNPELVAGK SDWELLNMPT KEIMDLLENA GSQIDEVKKR SARSGKNLQR LGKWLVPQTK
     HYSWMKAADI IGIGLDQVVP VPIDSNYRMD IQALESIIRK YAAEKTPILG VVGVAGSTEE
     GAVDGIDKIV ALRQKLQKEG IYFYLHVDAA YGGYARALFL DEDDQFIPYK NLQKVHAENH
     VFTEDKEYIK PEVYAAYKAF DQAESITIDP HKMGYVPYSA GGIVIQDIRM RDTISYFATY
     VFEKGADIPA LLGAYILEGS KAGATAASVW AAHHTLPLNV TGYGKLEGAS IEGAHRYYDF
     LKNLKFEVAG KRISVHPLIS PDFNMVDYVL KEDGNDDLIE MNRLNHAFYE QASYVKGSLY
     GKEYIVSHTD FAIPDYGDSP LAFVESLGFS EVEWRHAGKV TIIRASVMTP YMNQRENFDY
     FAPRIKKAIQ ADLEKVYASV NQKENV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024